John Niederhuber, M.D.

National Cancer Institute of the National Institutes of Health
Director Emeritus

Dr. John Niederbuber is the co-director to the John Hopkins’ Clinical Research Network and the previous Vice President and CEO of Inova Translation Medicine Institute. Prior to his time at NIH and Inova, he joined John Hopkins’ as a professor of surgery, oncology and molecular biology and genetics. In 1991, Dr. Niederhuber accepted the role of Stanford’s Emile Holman Professor of Surgery, Microbiology, and Immunology, and Chair of the Department of Surgery.

From 2006 to 2010, Dr. Niederhuber served as the 13th director of the National Cancer Institute. There, he started the Cancer Genome Atlas and led studies that researched tissue stem cells as the cell of origin for cancer through NCI’s Laboratory of Tumor and Stem Cell Biology. His research has had great influence in research areas such as the subcellular imaging of cancer and nanobiology.

Here at Sus Clinicals, Dr. Niederhuber shares his expertise and advises the company on industry and scientific matters to support Sus’ continued expansion of meaningful products and services.